Oneness Biotech Co., Ltd.

Taipei Exchange:4743.TWO

Location

Market Cap

USD 1.06 B

Share Price

USD 2.21

Avg Daily Volume

2,132,457

Change (1 day)

-1.72%

Change (1 year)

-52.05%

Change (YTD)

-16.85%

Oneness Biotech Co., Ltd. Shareholders' Equity for the year ending December 31, 2024: USD 374.55 M

Oneness Biotech Co., Ltd. Shareholders' Equity is USD 374.55 M for the year ending December 31, 2024, a -18.18% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Oneness Biotech Co., Ltd. Shareholders' Equity for the year ending December 31, 2023 was USD 457.77 M, a -4.00% change year over year.
  • Oneness Biotech Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 476.84 M, a -5.69% change year over year.
  • Oneness Biotech Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 505.63 M, a 4.32% change year over year.
  • Oneness Biotech Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 484.69 M, a 129.17% change year over year.
Key data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory
Market news
Loading...
Taipei Exchange: 4743.TWO

Oneness Biotech Co., Ltd.

CEO Mr. Nien-Yi Chen
IPO Date Sept. 23, 2011
Location Taiwan
Headquarters No.236, Xinyi Road
Employees 180
Sector 🏥 Health Care
Industries
Description

Oneness Biotech Co., Ltd engages in the research and development of new drugs, and sale of pharmaceutical and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti-cancer drug that is in Phase I clinical trials. It is also developing FB704A that has completed Phase I clinical trial for the treatment of rheumatoid arthritis and systemic sclerosis; FB825, which is in Phase II clinical trial for treating atopic dermatitis, allergic diseases, and asthma; and FB918, a human monoclonal antibody, which is in pre-clinical stage for the treatment of allergic asthma. In addition, the company engages in the management of agriculture cultivation and trading business; and sale of agricultural products. The company was incorporated in 2008 and is headquartered in Taipei City, Taiwan.

Similar companies

ABBV

AbbVie Inc.

USD 182.31

-2.40%

NOVO-B.CO

Novo Nordisk A/S

USD 68.56

1.71%

RO.SW

Roche Holding AG

USD 347.50

0.20%

ABT

Abbott Laboratories

USD 134.38

0.53%

NOVN.SW

Novartis AG

USD 120.31

0.29%

AZN.L

AstraZeneca PLC

USD 140.24

0.73%

MRK

Merck & Co., Inc.

USD 79.10

0.34%

AMGN

Amgen Inc.

USD 277.13

-0.71%

PFE

Pfizer Inc.

USD 24.19

-0.21%

GILD

Gilead Sciences, Inc.

USD 110.67

2.83%

SAN.PA

Sanofi

USD 96.65

0.37%

VRTX

Vertex Pharmaceuticals Incorporated

USD 441.30

-0.47%

BMY

Bristol-Myers Squibb Company

USD 46.35

-0.64%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 51.91

-1.13%

GSK.L

GSK plc

USD 19.28

0.69%

CSL.AX

CSL Limited

USD 153.01

-2.58%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 131.98

1.04%

REGN

Regeneron Pharmaceuticals, Inc.

USD 521.00

0.00%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

-0.32%

4502.T

Takeda Pharmaceutical Company Limited

USD 30.16

-0.03%

ALNY

Alnylam Pharmaceuticals, Inc.

USD 322.83

1.44%

UCB.BR

UCB SA

USD 199.41

0.97%

GEHC

GE HealthCare Technologies Inc.

USD 74.38

-0.64%

BAYN.DE

Bayer AG

USD 31.61

2.81%

068270.KS

Celltrion, Inc.

USD 116.73

-0.46%

2359.HK

WuXi AppTec Co., Ltd.

USD 9.68

-1.75%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.71

-0.01%

LH

Laboratory Corporation of America Holdings

USD 260.59

1.41%

INSM

Insmed Incorporated

USD 99.49

-2.21%

RPRX

Royalty Pharma plc

USD 35.87

1.70%

BIIB

Biogen Inc.

USD 126.08

-0.66%

4503.T

Astellas Pharma Inc.

USD 9.69

0.99%

1801.HK

Innovent Biologics, Inc.

USD 9.85

-1.60%

SMMT

Summit Therapeutics Inc.

USD 20.60

-3.38%

4507.T

Shionogi & Co., Ltd.

USD 17.51

-0.68%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 39.09

3.96%

GMAB.CO

Genmab A/S

USD 205.20

-0.79%

NBIX

Neurocrine Biosciences, Inc.

USD 125.42

-1.02%

EXEL

Exelixis, Inc.

USD 43.67

1.35%

MANKIND.NS

Mankind Pharma Limited

USD 27.30

1.56%

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.56

0.65%

RGC

Regencell Bioscience Holdings Limited

USD 17.40

-13.82%

9926.HK

Akeso, Inc.

USD 11.78

-2.48%

ASND

Ascendis Pharma A/S

USD 172.22

-0.42%

LUPIN.NS

Lupin Limited

USD 22.64

0.60%

BMRN

BioMarin Pharmaceutical Inc.

USD 55.17

1.98%

SOBI.ST

Swedish Orphan Biovitrum AB (publ)

USD 29.88

2.57%

IPN.PA

Ipsen S.A.

USD 120.09

-0.15%

000963.SZ

Huadong Medicine Co., Ltd

USD 5.63

0.53%

StockViz Staff

June 30, 2025

Any question? Send us an email